ELIZABETH BAUMSTARK: Open Payments
NPI 1871839878 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 59 payments from 6 companies in 2025. Trend: 2023 $204 · 2024 $931 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $690 |
| Janssen Biotech, Inc. | 7 | $155 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Lilly USA, LLC | 1 | $23 |
Products named: RINVOQ, SKYRIZI, TREMFYA, ZENPEP, ENTYVIO, XIFAXAN, OMVOH.
Industry payments across TN — which companies pay providers there.
